---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-106102"
form_type: "8-K"
ticker: "TOVX"
cik: "0000894158"
company_name: "Theriva Biologics, Inc."
filed_at: "2023-10-03T23:59:59+00:00"
generated_at: "2026-06-10T05:57:21.639567+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Theriva Biologics announces 2023 annual meeting voting results; directors elected, auditor ratified

## Summary
- Four directors elected: Kraws, Shallcross, Monahan, Wolf; votes for ranged from 1,996,551 to 2,553,173, with 4,077,933 broker non-votes each.
- Ratification of BDO USA P.C. as independent auditor for FY 2023: 7,059,989 for, 171,037 against, 182,495 abstentions.
- Meeting held October 2, 2023; no other proposals voted on.

## SEC filing metadata
- accession: 0001104659-23-106102
- form_type: 8-K
- ticker: TOVX
- cik: 0000894158
- company_name: Theriva Biologics, Inc.
- filed_at: 2023-10-03T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/894158/000110465923106102/0001104659-23-106102-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/894158/000110465923106102/tm2327462d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-106102
- JSON: https://secwatch.observer/filing/0001104659-23-106102.json
- Plain text: https://secwatch.observer/filing/0001104659-23-106102.txt

## Key facts
- Shareholder Votes
  Theriva Biologics, Inc. shareholders approved Ratification of the appointment of BDO USA P.C. as the Company’s independent registered public accounting firm for the year ending December 31, 2023 at the 2023-10-02 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-10-02
  source text: Proposal 2 — Ratification of the appointment of BDO USA P.C. as the Company’s independent registered public accounting firm for the year ending December 31, 2023. The stockholders ratified and approved the appointment
  evidence_url: https://www.sec.gov/Archives/edgar/data/894158/000110465923106102/0001104659-23-106102-index.htm
- Shareholder Votes
  Theriva Biologics, Inc. shareholders approved Election of Directors at the 2023-10-02 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-10-02
  source text: Proposal 1 — Election of Directors . The following four (4) individuals were elected as directors
  evidence_url: https://www.sec.gov/Archives/edgar/data/894158/000110465923106102/0001104659-23-106102-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.